At recurrence, it progressed to GBM, with the typical features of this tumor type described above (amplification of EGFR, gain at chr7, and losses at chr9p24.3-p21.1, chr10p15.3-q26.3, chr13, and chr22). The gene discussed is EGFR; the disease is glioblastoma.